Horizon Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.49M Buy
7,842
+2,793
+55% +$1.24M 0.06% 258
2025
Q1
$2.45M Buy
5,049
+80
+2% +$38.8K 0.07% 172
2024
Q4
$2M Buy
4,969
+86
+2% +$34.6K 0.06% 186
2024
Q3
$2.27M Sell
4,883
-55
-1% -$25.6K 0.06% 159
2024
Q2
$2.31M Sell
4,938
-134
-3% -$62.8K 0.06% 143
2024
Q1
$2.12M Buy
5,072
+182
+4% +$76.1K 0.06% 155
2023
Q4
$1.99M Buy
4,890
+403
+9% +$164K 0.06% 149
2023
Q3
$1.56M Buy
4,487
+56
+1% +$19.5K 0.05% 137
2023
Q2
$1.56M Sell
4,431
-196
-4% -$69K 0.04% 138
2023
Q1
$1.46M Sell
4,627
-2,636
-36% -$831K 0.04% 137
2022
Q4
$2.1M Sell
7,263
-3,638
-33% -$1.05M 0.06% 130
2022
Q3
$3.16M Buy
10,901
+7,448
+216% +$2.16M 0.1% 82
2022
Q2
$973K Sell
3,453
-7,917
-70% -$2.23M 0.03% 185
2022
Q1
$2.97M Buy
11,370
+1,904
+20% +$497K 0.08% 112
2021
Q4
$2.08M Buy
9,466
+6,725
+245% +$1.48M 0.06% 139
2021
Q3
$497K Sell
2,741
-839
-23% -$152K 0.01% 318
2021
Q2
$722K Buy
3,580
+1,128
+46% +$227K 0.02% 258
2021
Q1
$527K Buy
+2,452
New +$527K 0.02% 285
2020
Q4
Sell
-7,238
Closed -$1.97M 394
2020
Q3
$1.97M Buy
7,238
+2,380
+49% +$648K 0.07% 127
2020
Q2
$1.41M Buy
4,858
+1,640
+51% +$476K 0.03% 191
2020
Q1
$766K Buy
3,218
+393
+14% +$93.5K 0.04% 144
2019
Q4
$619K Buy
2,825
+1,233
+77% +$270K 0.03% 247
2019
Q3
$270K Sell
1,592
-87
-5% -$14.8K 0.01% 279
2019
Q2
$308K Buy
1,679
+348
+26% +$63.8K 0.01% 363
2019
Q1
$245K Buy
+1,331
New +$245K 0.01% 312